ROCKET PHARMA Trademark

Trademark Overview


On Friday, February 9, 2024, a trademark application was filed for ROCKET PHARMA with the United States Patent and Trademark Office. The USPTO has given the ROCKET PHARMA trademark a serial number of 98399453. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, October 29, 2025. This trademark is owned by Rocket Pharmaceuticals GmbH. The ROCKET PHARMA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical and health information in the field of genetic diseases and disorders; providing information in the field of genetic diseases and disorders treatment for medical purposes; Providing links to the web sites of others featuring medical and health information about genetic diseases and disorders; providing links to the web sites of others featuring information about the diagnosis and treatment of genetic diseases and disorder

Research and development of pharmaceuticals for the treatment of genetic diseases and disorders; medical and scientific research services in the field of genetic disease and disorder treatment

Pharmaceutical preparations for the treatment of genetic diseases and disorders
rocket pharma

General Information


Serial Number98399453
Word MarkROCKET PHARMA
Filing DateFriday, February 9, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, October 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements


Pseudo MarkROCKET PHARMACEUTICALS
Goods and ServicesProviding medical and health information in the field of genetic diseases and disorders; providing information in the field of genetic diseases and disorders treatment for medical purposes; Providing links to the web sites of others featuring medical and health information about genetic diseases and disorders; providing links to the web sites of others featuring information about the diagnosis and treatment of genetic diseases and disorder
NOT AVAILABLE"PHARMA"
Indication of Colors claimedThe color(s) white, red, black, and grey is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of pharmaceuticals for the treatment of genetic diseases and disorders; medical and scientific research services in the field of genetic disease and disorder treatment
Goods and ServicesPharmaceutical preparations for the treatment of genetic diseases and disorders
Description of MarkThe mark consists of the stylized wording "ROCKET PHARMA" with the term "ROCKET" in black and the term "PHARMA" in grey. To the left of the wording is a cluster of five hexagons. The top four hexagons appear in red. The bottom hexagon appears in white outlined in red.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRocket Pharmaceuticals GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressZug 6300
CH

Party NameRocket Pharmaceuticals GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressZug 6300
CH

Trademark Events


Event DateEvent Description
Friday, February 9, 2024NEW APPLICATION ENTERED
Monday, June 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 10, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 3, 2024ASSIGNED TO EXAMINER
Tuesday, September 3, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, December 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, January 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 5, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 5, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, February 5, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 5, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, February 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 29, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 29, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, October 29, 2025SOU EXTENSION 1 FILED
Wednesday, October 29, 2025SOU EXTENSION 1 GRANTED
Thursday, October 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED